A total of 2306 patients were enrolled in the initial open-label phase of the study. Of these, 627 patients who showed a suboptimal response after 8 weeks of treatment with olmesartan medoxomil 20 ...

Treatment differences were determined for olmesartan medoxomil plus hydrochlorothiazide versus olmesartan medoxomil (C vs A) and for olmesartan medoxomil plus hydrochlorothiazide versus ...